scispace - formally typeset
Open AccessJournal ArticleDOI

Bacterial Translocation Associates With Aggression in Schizophrenia Inpatients.

Reads0
Chats0
TLDR
In this paper, the authors evaluated the associations among aggression, inflammation, and bacterial translocation (BT) in aggression-affected schizophrenia (ScZ) inpatients with 2 weeks of antipsychotics discontinuation.
Abstract
Objective: Accumulating evidence indicates that inflammation abnormalities may contribute to aggression behaviors in psychotic patients, however, the possible sources of inflammation remain elusive. We aimed to evaluate the associations among aggression, inflammation, and bacterial translocation (BT) in aggression-affected schizophrenia (ScZ) inpatients with 2 weeks of antipsychotics discontinuation. Methods: Serum specimens collected from 112 aggression and 112 non-aggression individuals with ScZ and 56 healthy adults were used for quantifications of inflammation- or BT-related biomarkers. Aggression severity was assessed by Modified Overt Aggression Scale (MOAS). Results: Proinflammation phenotype dominated and leaky gut-induced BT occurred only in cases with ScZ with a history of aggression, and the MOAS score positively related to levels of C-reactive protein, interleukin (IL)-6, IL-1β, and tumor necrosis factor-α. Furthermore, serum levels of BT-derived lipopolysaccharide (LPS), as well as LPS-responded soluble CD14, were not only positively correlated with levels of above proinflammation mediators but also the total MOAS score and subscore for aggression against objects or others. Conclusion: Our results collectively demonstrate the presence of leaky gut and further correlate BT-derived LPS and soluble CD14 to onset or severity of aggression possibly by driving proinflammation response in inpatients with ScZ, which indicates that BT may be a novel anti-inflammation therapeutic target for aggression prophylaxis.

read more

Content maybe subject to copyright    Report

Citations
More filters
Journal ArticleDOI

Altered gut microbiota and its metabolites correlate with plasma cytokines in schizophrenia inpatients with aggression

TL;DR: In this article , the authors determined the gut microbiota and its metabolites, and clarified their correlations with inflammation, oxidation, leaky gut and clinical profiles underlying aggression in schizophrenia (ScZ).
Journal ArticleDOI

Alterations in innate immune defense distinguish first-episode schizophrenia patients from healthy controls

TL;DR: In this paper , the authors evaluated whether circulating endotoxin, high mobility group box 1 protein (HMGB1) and complement component 4 (C4) could act as peripheral biomarkers to distinguish first-episode schizophrenia patients from healthy controls in associations with psychopathological symptoms and cognitive dysfunctions.
Journal ArticleDOI

The Role of Lactylation in Mental Illness: Emphasis on Microglia

TL;DR: In this paper , the authors examined three anti-inflammatory microglial systems relevant for neuropsychiatry: lactate, oxytocin, and the aryl hydrocarbon receptor.
Journal ArticleDOI

Bacterial DNA promoting inflammation via the Sgk1/Nedd4L/Syk pathway in mast cells contributes to antihistamine non-responsive CSU.

TL;DR: In this article , a strong positive association between inflammation and fecal Escherichia was uncovered, and btDNA was found to positively correlate with the degree of inflammation in patients with non-sedating H1-antihistamines (nsAH) resistance.
References
More filters
Journal ArticleDOI

Meta-Analysis of Cytokine Alterations in Schizophrenia: Clinical Status and Antipsychotic Effects

TL;DR: Similar effect sizes in AR and FEP suggest that the association between cytokine abnormalities and acute exacerbations of schizophrenia is independent of antipsychotic medications.
Journal ArticleDOI

Gut-Microbiota-Brain Axis and Its Effect on Neuropsychiatric Disorders With Suspected Immune Dysregulation

TL;DR: Recognition of the relationship between the MGB axis and the neuroimmune systems provides a novel approach for better understanding and management of these disorders.
Journal ArticleDOI

Real-World Effectiveness of Antipsychotic Treatments in a Nationwide Cohort of 29 823 Patients With Schizophrenia

TL;DR: Clozapine and long-acting injectable antipsychotic medications were the pharmacologic treatments with the highest rates of prevention of relapse in schizophrenia.
Journal ArticleDOI

The role of inflammation in schizophrenia

TL;DR: Anti-inflammatory effects of antipsychotics, therapeutic effects of anti-inflammtory compounds, genetic, biochemical, and immunological findings point to a major role of inflammation in schizophrenia.
Related Papers (5)